Literature DB >> 1125699

Effects of truncal, selective, and highly selective vagotomy on glucose tolerance and insulin secretion in patients with duodenal ulcer. Part II-Comparison of response to oral and intravenous glucose.

C S Humphrey, J R Dykes, D Johnston.   

Abstract

Paired oral and intravenous glucose tolerance tests were carried out in patients who had undergone truncal vagotomy and pyloroplasty, selective vagotomy and pyloroplasty, or highly selective vagotomy at least six months earlier. Intravenous glucose tolerance was similar in all three groups. Oral glucose elicited significantly higher concentrations of plasma insulin in patients who had undergone selective and highly selective vagotomy than in those treated by truncal vagotomy. When the same amount of glucose was given intravenously, however, plasma insulin concentrations were similar in all three groups of patients. The insulin secreted in response to intravenous glucose expressed as a percentage of that secreted in response to oral glucose was 112% for truncal vagotomy, 51% for selective vagotomy, and 52% for highly selective vagotomy. Truncal vagotomy thus led to a diminished insulin response to oral glucose, which was probably due to impaired release of small-bowel hormones.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1125699      PMCID: PMC1673070          DOI: 10.1136/bmj.2.5963.114

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  24 in total

1.  HYPOGLYCEMIC VAGAL STIMULATION AND THE INTESTINAL PHASE OF GASTRIC SECRETION.

Authors:  K A KELLY; L M NYHUS; H N HARKINS
Journal:  J Surg Res       Date:  1964-09       Impact factor: 2.192

2.  CONTRACTION OF THE GALL BLADDER BEFORE AND AFTER TOTAL ABDOMINAL VAGOTOMY.

Authors:  J N GLANVILLE; H L DUTHIE
Journal:  Clin Radiol       Date:  1964-10       Impact factor: 2.350

3.  PLASMA INSULIN RESPONSE TO ORAL AND INTRAVENOUS GLUCOSE ADMINISTRATION.

Authors:  H ELRICK; L STIMMLER; C J HLAD; Y ARAI
Journal:  J Clin Endocrinol Metab       Date:  1964-10       Impact factor: 5.958

4.  The effect of truncal and selective vagotomy on the release of pancreatic glucagon, insulin and enteroglucagon.

Authors:  R C Russell; J P Thomson; S R Bloom
Journal:  Br J Surg       Date:  1974-10       Impact factor: 6.939

5.  Late metabolic sequelae of vagotomy and gastroenterostomy.

Authors:  E J Wheldon; C W Venables; I D Johnston
Journal:  Lancet       Date:  1970-02-28       Impact factor: 79.321

6.  Effect of vagotomy on hormones stimulating pancreatic secretion.

Authors:  S J Konturek; H D Becker; J C Thompson
Journal:  Arch Surg       Date:  1974-05

7.  Gallbladder volume and contractility after truncal, selective and highly selective (parietal-cell) vagotomy in man.

Authors:  G J Parkin; R B Smith; D Johnston
Journal:  Ann Surg       Date:  1973-11       Impact factor: 12.969

8.  Altered pancreatic and biliary function after vagotomy and pyloroplasty.

Authors:  J R Malagelada; V L Go; W H Summerskill
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

9.  Effect of vagotomy on pancreatic secretion evoked by endogenous and exogenous cholecystokinin and caerulein.

Authors:  S J Konturek; T Radecki; J Biernat; P Thor
Journal:  Gastroenterology       Date:  1972-08       Impact factor: 22.682

10.  Intestinal factors in the control of insulin secretion.

Authors:  N McIntyre; C D Holdsworth; D S Turner
Journal:  J Clin Endocrinol Metab       Date:  1965-10       Impact factor: 5.958

View more
  2 in total

Review 1.  Effect of vagotomy on gastrointestinal hormones.

Authors:  H D Becker; H W Börger; A Schafmayer
Journal:  World J Surg       Date:  1979-09-20       Impact factor: 3.352

2.  Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty.

Authors:  Astrid Plamboeck; Simon Veedfald; Carolyn F Deacon; Bolette Hartmann; André Wettergren; Lars B Svendsen; Søren Meisner; Claus Hovendal; Filip K Knop; Tina Vilsbøll; Jens J Holst
Journal:  Eur J Endocrinol       Date:  2013-07-06       Impact factor: 6.664

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.